Growth Metrics

Travere Therapeutics (TVTX) Cash from Investing Activities (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 120.55%
Dec 31, 2025 -221.07%
Sep 30, 2025 1,685.38%
Jun 30, 2025 -88.25%
Mar 31, 2025 151.41%
Dec 31, 2024 -274.11%
Sep 30, 2024 61.22%
Jun 30, 2024 -72.73%
Mar 31, 2024 146.76%
Dec 31, 2023 -268.28%
Sep 30, 2023 666.03%
Jun 30, 2023 36.41%
Mar 31, 2023 -0.92%
Dec 31, 2022 -464.13%
Sep 30, 2022 125.78%
Jun 30, 2022 -217.88%
Mar 31, 2022 350.00%
Dec 31, 2021 -77.34%
Sep 30, 2021 145.29%
Jun 30, 2021 32.07%
Mar 31, 2021 15.78%
Dec 31, 2020 -190.74%
Sep 30, 2020 -163.67%
Jun 30, 2020 71.43%
Mar 31, 2020 2,403.23%
Dec 31, 2019 -64.61%
Sep 30, 2019 -82.30%
Jun 30, 2019 321.08%
Mar 31, 2019 76.62%
Dec 31, 2018 69.79%
Sep 30, 2018 -678.87%
Jun 30, 2018 233.84%
Mar 31, 2018 -20,143.69%
Dec 31, 2017 95.29%
Sep 30, 2017 -105.00%
Jun 30, 2017 961.04%
Mar 31, 2017 -86.46%
Dec 31, 2016 603.47%
Sep 30, 2016 -41.01%
Jun 30, 2016 56.01%
Mar 31, 2016 90.29%
Dec 31, 2015 -292.37%
Sep 30, 2015 3,462.65%
Jun 30, 2015 94.96%
Mar 31, 2015 -1,663.96%
Dec 31, 2014 195.49%
Sep 30, 2014 65.94%
Jun 30, 2014 80.53%
Mar 31, 2014 -2,560.66%